KONINKLIJKE PHILIPS NV (PHIA.AS)
NL0000009538 - Common Stock
Taking everything into account, PHIA scores 3 out of 10 in our fundamental rating. PHIA was compared to 56 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHIA was profitable.
In the past year PHIA had a positive cash flow from operations.
In multiple years PHIA reported negative net income over the last 5 years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
PHIA has a Return On Assets of -1.43%. This is comparable to the rest of the industry: PHIA outperforms 40.74% of its industry peers.
PHIA has a Return On Equity of -3.54%. This is comparable to the rest of the industry: PHIA outperforms 40.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROIC | N/A |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA's Operating Margin has declined in the last couple of years.
The Gross Margin of PHIA (41.56%) is worse than 70.37% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
PHIA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% |
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHIA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHIA has more shares outstanding
PHIA has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.62, we must say that PHIA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PHIA (1.62) is comparable to the rest of the industry.
PHIA has a debt to FCF ratio of 7.27. This is a slightly negative value and a sign of low solvency as PHIA would need 7.27 years to pay back of all of its debts.
PHIA has a Debt to FCF ratio (7.27) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.60 indicates that PHIA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.60, PHIA is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Altman-Z | 1.62 |
ROIC/WACCN/A
WACC6%
2.3 Liquidity
A Current Ratio of 1.16 indicates that PHIA should not have too much problems paying its short term obligations.
With a Current ratio value of 1.16, PHIA is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
A Quick Ratio of 0.74 indicates that PHIA may have some problems paying its short term obligations.
PHIA has a worse Quick ratio (0.74) than 68.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
PHIA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.95%.
Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.67% on average per year.
PHIA shows a small growth in Revenue. In the last year, the Revenue has grown by 1.92%.
Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 0.05% on average per year.
EPS 1Y (TTM)3.95%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-1.93%
Revenue 1Y (TTM)1.92%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-0.51%
3.2 Future
Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.13% on average per year.
The Revenue is expected to grow by 4.56% on average over the next years.
EPS Next Y23.76%
EPS Next 2Y14.78%
EPS Next 3Y15.12%
EPS Next 5Y16.13%
Revenue Next Year0.67%
Revenue Next 2Y2.65%
Revenue Next 3Y3.3%
Revenue Next 5Y4.56%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
PHIA is valuated rather expensively with a Price/Earnings ratio of 18.78.
77.78% of the companies in the same industry are more expensive than PHIA, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 30.69, PHIA is valued a bit cheaper.
The Price/Forward Earnings ratio is 14.83, which indicates a correct valuation of PHIA.
Based on the Price/Forward Earnings ratio, PHIA is valued cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PHIA to the average of the S&P500 Index (22.55), we can say PHIA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.78 | ||
| Fwd PE | 14.83 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as PHIA.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 94.44% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.91 | ||
| EV/EBITDA | 30.06 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHIA's earnings are expected to grow with 15.12% in the coming years.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y14.78%
EPS Next 3Y15.12%
5. Dividend
5.1 Amount
PHIA has a Yearly Dividend Yield of 4.15%, which is a nice return.
Compared to an average industry Dividend Yield of 2.41, PHIA pays a better dividend. On top of this PHIA pays more dividend than 98.15% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.22, PHIA pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
5.2 History
The dividend of PHIA decreases each year by -65.46%.
Dividend Growth(5Y)-65.46%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of PHIA are negative and hence is the payout ratio. PHIA will probably not be able to sustain this dividend level.
DP-0.48%
EPS Next 2Y14.78%
EPS Next 3Y15.12%
KONINKLIJKE PHILIPS NV
AMS:PHIA (10/30/2024, 7:00:00 PM)
24.23
-0.86 (-3.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap22.63B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.78 | ||
| Fwd PE | 14.83 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.79
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.95%
EPS 3Y-15.7%
EPS 5Y
EPS Q2Q%
EPS Next Y23.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.92%
Revenue growth 3Y1.62%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y